Use of RBD as diagnostic, treatment or vaccine of COVID-19

摘要

The present invention relates to the use of RBD for a vaccine or diagnosis of coronavirus infection-19, specifically, the present invention relates to novel coronavirus 19 (SARS-CoV-2) consisting of the amino acid sequence of the RBD protein represented by SEQ ID NO: 2 ), a diagnostic composition for coronavirus infection-19 and a therapeutic pharmaceutical composition comprising the antigenic protein as an active ingredient, and the present invention relates to a method for mass production of an RBD antigenic protein. When using the RBD antigen protein according to the present invention, it is possible to quickly and accurately diagnose the onset of coronavirus infection-19 (COVID-19) based on the serum of a patient with symptoms or a patient with few or no symptoms. there is an effect